Cargando…
Identification of novel myelin repair drugs by modulation of oligodendroglial differentiation competence
BACKGROUND: In multiple sclerosis loss of myelin and oligodendrocytes impairs saltatory signal transduction and leads to neuronal loss and functional deficits. Limited capacity of oligodendroglial precursor cells to differentiate into mature cells is the main reason for inefficient myelin repair in...
Autores principales: | Manousi, Anastasia, Göttle, Peter, Reiche, Laura, Cui, Qiao-Ling, Healy, Luke M., Akkermann, Rainer, Gruchot, Joel, Schira-Heinen, Jessica, Antel, Jack P., Hartung, Hans-Peter, Küry, Patrick |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7970057/ https://www.ncbi.nlm.nih.gov/pubmed/33714029 http://dx.doi.org/10.1016/j.ebiom.2021.103276 |
Ejemplares similares
-
Teriflunomide promotes oligodendroglial differentiation and myelination
por: Göttle, Peter, et al.
Publicado: (2018) -
Myelin repair is fostered by the corticosteroid medrysone specifically acting on astroglial subpopulations
por: Silva Oliveira Junior, Markley, et al.
Publicado: (2022) -
C21orf91 Regulates Oligodendroglial Precursor Cell Fate—A Switch in the Glial Lineage?
por: Reiche, Laura, et al.
Publicado: (2021) -
Teriflunomide as a therapeutic means for myelin repair
por: Göttle, Peter, et al.
Publicado: (2023) -
CXCR7 Is Involved in Human Oligodendroglial Precursor Cell Maturation
por: Kremer, David, et al.
Publicado: (2016)